The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) detection of molecular residual disease (MRD) as a potential biomarker in localized soft tissue sarcoma (STS).
 
Abdulazeez Salawu
No Relationships to Disclose
 
Elizabeth Demicco
No Relationships to Disclose
 
Peter W. M. Chung
Honoraria - Abbvie; AstraZeneca; Boston Scientific
Consulting or Advisory Role - Tersera; Tolmar; Verity Pharmaceuticals
Research Funding - Abbvie
 
Jordan Feeney
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Jasmine Lee
No Relationships to Disclose
 
Eoghan Ruadh Malone
No Relationships to Disclose
 
Charles Catton
Honoraria - Abbvie; Bayer; Knight Therapeutics; Tersera
 
Limore Arones
No Relationships to Disclose
 
Madeline J. Phillips
No Relationships to Disclose
 
Philip Wong
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Jay Wunder
No Relationships to Disclose
 
Peter Charles Ferguson
No Relationships to Disclose
 
Stephen Willingham
Employment - Corvus Pharmaceuticals; Natera
Stock and Other Ownership Interests - Atreca; Bolt Biotherapeutics; Corvus Pharmaceuticals; Forty Seven; Iovance Biotherapeutics; Moderna Therapeutics; Natera
Consulting or Advisory Role - Corvus Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Corvus Pharmaceuticals; Forty Seven; Natera
Travel, Accommodations, Expenses - Natera
Other Relationship - Fred Hutchinson Cancer Research Center (I); Sutter Health (I)
 
David Benjamin Shultz
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
Consulting or Advisory Role - Adaptimmune; Bayer; GlaxoSmithKline; Inhibrx; Medison
Research Funding - Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Bristol-Myers Squibb; Daiichi Sankyo; Deciphera; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; MedImmune; Merck; Neoleukin Therapeutics; Pfizer; Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison